It Has Been Sent without "Thesma**......But Signed by

New Post Public Reply Private Reply Replies (1) Message Board
mag1
It Has Been Sent without "Thesma**......But Signed by Me

Mark Gotham <windrivermag@gmail.com>
12:39 PM (11 minutes ago)

to ir
Dear IR,
Recently posted on HangOut...The Board....I would certainly Strongly Suggest a Conference Call...Probably Post 10q.....If 10q is ready.....Post it...

i am disappointed in the new IR strategy. they continue to give some rather vague responses or misdirects to some rather basic questions. they were quick to pat themselves on the back and defend their performance when the price moved to low 20s. they should be equally quick to take the blame for the fall.

what is the rationale for NOT putting out a PR for a $135MM SLA if it is "set in stone" as IR is alluding to. this is a BFD for any size company let alone a fledgling start up. prior guidance by IR was no PRs with awards under $250K. so - why would this NOT warrant a specific PR to promote the company/stock beyond this message board/OTC sites?

why is it so difficult to provide specific and straightforward guidance for 2016 year end? too much double speak, platitudes, and light at the end of the tunnel BS. is this an IR thing, Bill thing, or both? even if the guidance has a rather large spread and variance - put it in writing and put some conviction to it. i invested based on the business plan and meeting early milestones and making progress on the rest. it shouldn't take 90 days to provide basic guidance. be conservative but specific and then adjust up accordingly.

how is IR compensated/who are they? again - this still has not been answered. are they being paid with shares? cash? options? are they employees or contract? investors? are they based in US or in China? why cant this be answered straightforward?

address the share count - AS and OS. many us of added based on decreasing OS per Bill and then it goes back up. Bill specifically pointed out one error but that does not account for another 500MM + swing upwards.

why cant the schedule another CC? i have asked this of IR and Bill directly.

some on here are saying "accumulate" but that is what many long term shareholders were doing in the 40s, 30s, 20s, and then high teens. i have dramatically increased my position from original 0.0003-0.0004 cost basis with 8 figure share count.

right now - i am not enthralled by the current lack of answers to some basic questions that Bill directly and passionately addressed on last CC. there is nothing definitive with the $135MM SLA announced and those revenues are significantly moved out into the future (see above on PR). unfortunately, there is no reason to "buy big" here when there is obviously someone dumping/converting shares continuously through VNDM or a shitonne of manipulation going on. Either way - it needs to be addressed much more vehemently than it was in the one tweet. unfortunately - we ARE on the OTC and it requires the CEO to act/react to certain stock price trends differently than if we were on the big boards.

i am just now looking at price action today. CDEL has 2.2MM shares at $0.0017 which could just be the two tick flipper from the large $0.15 purchase last week. 12-15MM shares were taken at $0.0017 off the BID yesterday. how many shares is VNDM unloading and where are they coming from...? this isnt just retail.

IR needs to get in front of this resolutely if they want to establish real credibility and drive the company forward. MRVB is NOT a driving force for investors. while that may provide future stability - it is NOT the reason we are investing long term.

get back to the business strategy/plan basics. confirm when guidance will occur (end of original 90 days?). tell the broad market about the meat and potatoes behind the $135MM SLA.

if this doesnt start happening - this could see trips quick. while there is a lot of talk about long term on this board - my guess there are precious few who are willing to wait 1-2 years and will bail before they go into the red on manipulative trading. too many bad actors on the OTC to believe in the "trust us" mantra. Reagan adage applies - trust buy verify. IR is falling short on the verify part right now.
(4) (0)

Sincerely Mark Gotham Substantial TPAC Share Holder

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

GE HealthCare Launches Innovative Ultrasound Systems for Women

Updated Category News Views 289

GE HealthCare Unveils New Voluson Expert Series Ultrasound Systems GE HealthCare recently announced the launch of its enhanced Voluson Expert Series ultrasound systems, aiming to improve early detection and streamline exam efficiency in women's healthcare. With FDA 510(k) clearance achieved, these innovative systems—Voluson Expert 22, 20, and 18—combine...

Continue Reading
Newmont Corp: Dominating Gold Mining with Impressive Gains

Updated Category News Views 291

Newmont Corp's Standout Performance In a market filled with technology giants, Newmont Corp (NYSE: NEM) is making headlines for its remarkable performance this year. Rising an astonishing 106% year-to-date (YTD), the largest gold miner is turning ore into a sought-after treasure for investors. The stability of gold prices amid ongoing inflation concerns has positioned...

Continue Reading
Seeking Justice: Class Action Lawsuit for Fiserv, Inc. Investors

Updated Category News Views 221

Overview of the Fiserv, Inc. Class Action Investors who have experienced significant losses in Fiserv, Inc. (NYSE: FI) stock are encouraged to take action. Robbins LLP is currently leading a class action lawsuit, aimed at helping those impacted during a specific class period of the company’s troubling financial disclosures. Why Join the Class Action? This initiative is...

Continue Reading
Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Updated Category News Views 262

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Continue Reading
Probe Gold's Annual Meeting Highlights Key Voting Outcomes

Updated Category News Views 181

Key Highlights from Probe Gold's Annual General Meeting Probe Gold Inc., with its stock traded as TSX: PRB and OTCQB: PROBF, held its Annual General Meeting (AGM) where significant decisions were made that will shape the company's future. This meeting was filled with exciting developments as shareholders came together to participate in the governance of the company....

Continue Reading